JNJ vs CVS
By Alex · Tickerpine
Johnson & Johnson vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CVS |
|---|---|---|
| Price | $254.66 | $104.34 |
| Market cap | $613.02B | $133.13B |
| P/E ratio | 29.5 | 45.6 |
| ROE | 26.42% | 3.75% |
| Profit margin | 21.83% | 0.72% |
| Revenue growth | 9.90% | 6.10% |
| Dividend yield | 2.10% | 2.55% |
| Beta | 0.26 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CVS in plain English
- JNJ is the bigger company — about 4.6× the market cap of CVS.
- JNJ is cheaper on earnings (P/E 29.5 vs 45.6).
- JNJ earns a higher return on equity (26% vs 4%).
- JNJ is growing revenue faster (10% vs 6%).
- CVS has the higher dividend yield (2.55% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.